CAPORALI, ROBERTO FELICE
CAPORALI, ROBERTO FELICE
Dipartimento di Scienze Cliniche e di Comunità
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus
2024 F.S. Macaluso, F. Caprioli, L. Benedan, C. Bezzio, R. Caporali, A. Cauli, M.S. Chimenti, F. Ciccia, S. D'Angelo, M.C. Fantini, S. Festa, F. Iannone, E. Lubrano, P. Mariani, C. Papi, G. Provenzano, D. Pugliese, A. Rispo, S. Saibeni, C. Salvarani, A. Variola, M. Zenga, A. Armuzzi, A. Orlando, R. Gerli
Long-term use of burosumab for the treatment of tumor-induced osteomalacia
2023 C. Crotti, F. Zucchi, C. Alfieri, R. Caporali, M. Varenna
Owning Pets Reduces the Perception of Disease Activity in Patients With Rheumatoid Arthritis
2023 C. Posio, I. Suardi, R. Caporali, F. Ingegnoli
Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'
2023 C. Perricone, E. Bartoloni, G. Cafaro, R. Caporali, R. Gerli
Correspondence on 'Non-surgical and surgical treatments for rotator cuff disease: a pragmatic randomised clinical trial with 2-year follow-up after initial rehabilitation'
2023 P. Randelli, L.A. Coletto, A. Menon, R. Caporali
Olive Oil and Nuts in Rheumatoid Arthritis Disease Activity
2023 R. De Vito, F. Fiori, M. Ferraroni, S. Cavalli, R. Caporali, F. Ingegnoli, M. Parpinel, V. Edefonti
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission
2023 R. Giacomelli, R. Caporali, F. Ciccia, S. Colafrancesco, L. Dagna, M. Govoni, F. Iannone, P. Leccese, C. Montecucco, G. Pappagallo, G. Pistone, R. Priori, P. Ruscitti, P. Sfriso, L. Cantarini, N. Belfiore, C. Bernardi, M. Gabini, S. Bettio, A. Brucato, G. Italiano, F.P. Cantatore, D. Iacono, I. Pantano, E. Tirri, F. Ursini, A.L. Monaco, F. Caso, L. Quartuccio, M.S. Chimenti, A. Gattamelata, E. Gremese, M. Paroli, A. Picchianti-Diamanti, G.D. Sebastiani, E. Favalli, A. Sulli, M. Frassi, P. Faggioli, R. Foti, C. Campochiaro, G. Cavalli, A. Tomelleri, M. Manara, L. De Stefano, R. De Angelis, S. Parisi, G. Lopalco, M. Piga, D. Marotto, M. Colaci, A. Padula, G. Guggino, G. Emmi, C. Baldini, J. Sota, A. Vitale, A. Berti, E. Bartoloni, C. Grava, S. Bindoli, R. Vitetta
Case report: Prader-Willi syndrome and inflammatory arthritis-An important consideration
2023 L. Marelli, T. Dallos, E. Miserocchi, P. Nucci, B. Tombolini, O. De Lucia, M. Gattinara, R. Caporali, A. Marino
Disease activity and disease-related factors are drivers of patient global assessment in rheumatoid arthritis: a real-life cross-sectional study
2023 I. Suardi, C. Posio, E. Luconi, P. Boracchi, R. Caporali, F. Ingegnoli
Tight control in patients with rheumatoid arthritis treated with targeted therapies across the COVID-19 pandemic era
2023 A.F. Luppino, G. Cincinelli, A. Orenti, P. Boracchi, E.G. Favalli, R. Caporali, F. Ingegnoli
Pregnancy in juvenile idiopathic arthritis: maternal and foetal outcome, and impact on disease activity
2022 M. Gerosa, C.B. Chighizola, F. Pregnolato, I. Pontikaki, A.F. Luppino, L. Maria Argolini, L. Trespidi, M. Wally Ossola, E.M. Ferrazzi, R. Caporali, R. Cimaz
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort
2022 M. Gerosa, L. Beretta, G.A. Ramirez, E. Bozzolo, M. Cornalba, C. Bellocchi, L.M. Argolini, L. Moroni, N. Farina, G. Segatto, L. Dagna, R. Caporali
Myocardial involvement in anti-phospholipid syndrome: Beyond acute myocardial infarction
2022 L. Coletto, M. Gerosa, M. Valentini, R. Cimaz, R. Caporali, P. Meroni, C. Chighizola
Juvenile Idiopathic Arthritis, Uveitis and Multiple Sclerosis: Description of Two Patients and Literature Review
2022 C.B. Chighizola, M. Ferrito, L. Marelli, I. Pontikaki, P. Nucci, E. Miserocchi, R. Caporali
Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases
2022 S. Cavalli, P.A. Lonati, M. Gerosa, R. Caporali, R. Cimaz, C.B. Chighizola
Controversies in rheumatology: Ultrasound for monitoring of RA - do we need it?
2022 H.B. Hammer, R. Caporali
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update
2022 R.B.M. Landewé, F.P.B. Kroon, A. Alunno, A. Najm, J.W. Bijlsma, G.R. Burmester, R. Caporali, B. Combe, R. Conway, J.R. Curtis, O. Elkayam, L. Gossec, M.W. Heijstek, L. Haupt, A. Iagnocco, J.D. Isaacs, I.Á. Juhász, S. Makri, X. Mariette, I.B. Mcinnes, P. Mehta, U. Mueller-Ladner, H. Schulze-Koops, J.S. Smolen, D. Wiek, K.L. Winthrop, V. Navarro-Compán, P.M. Machado
Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence
2022 F. Iannone, F. Conti, A. Cauli, A. Farina, R. Caporali
Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study
2022 R. Alten, X. Mariette, R. Flipo, R. Caporali, M.H. Buch, Y. Patel, S. Marsal, R. Sanmartí, M.T. Nurmohamed, H. Griffiths, P. Peichl, B. Bannert, M. Chartier, S.E. Connolly, K. Lozenski, C. Rauch
Is adipose-tissue (or its fraction) grafting really effective in the treatment of scleroderma hand?
2022 N. Del Papa, C. Vitali, A. Minniti, R. Caporali